Molecular Partners Ag (MOLN) Non Operating Income (2022 - 2025)

Molecular Partners Ag (MOLN) posted quarterly Non Operating Income of -$3.7 million for Q2 2025, down 174.24% year-on-year from $5.0 million in Q2 2024, and down 174.24% on a QoQ basis from $5.0 million in Q2 2024.

Molecular Partners Ag (MOLN) Non Operating Income (2022 - 2025) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Non Operating Income for 4 consecutive years, with -$3.7 million the latest figure, recorded in Q2 2025.

  • Quarterly Non Operating Income fell 174.24% year-over-year to -$3.7 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $3.5 million (changed N/A YoY) and the FY2025 annual result came in at -$4.4 million, down 153.84% from the prior year.
  • Non Operating Income slipped to -$3.7 million in Q2 2025 per MOLN's latest filing, from $5.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for MOLN reached as high as $5.0 million in Q2 2024 and fell as low as -$3.7 million in Q2 2025.
  • A 4-year average of $868660.9 and a median of $1.1 million in 2023 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2024 — Non Operating Income surged 1353.87% — and 2025, when it sank 174.24%.
  • Year by year, Non Operating Income stood at $1.8 million in 2022, then tumbled by 81.25% to $344774.4 in 2023, then jumped by 1353.87% to $5.0 million in 2024, then plunged by 174.24% to -$3.7 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$3.7 million, $5.0 million, and $344774.4 for Q2 2025, Q2 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.72 Mn
Jun 30, 2024 5.01 Mn
Jun 30, 2023 344,774.42
Jun 30, 2022 1.84 Mn